ZIOP stock forecast
Our latest prediction for ZIOPHARM Oncology, Inc.'s stock price was made on the Nov. 8, 2017 when the stock price was at 4.72$.
In the short term (2weeks), ZIOP's stock price should outperform the market by 3.77%. During that period the price should oscillate between -8.21% and +11.72%.
In the medium term (3months), ZIOP's stock price should outperform the market by 4.57%. During that period the price should oscillate between -20.06% and +31.53%.Get email alerts
About ZIOPHARM Oncology, Inc.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -0.53$ per share.
The book value per share is -0.98$
Three months stock forecastNov. 8, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|